Niacin is a type of B vitamin.niacin can boost levels of good HDL cholesterol and lower triglycerides.

Cullinan Oncology Reveals FDA Approval for Initial Trials of Unique MICA/B Antibody, CLN-619, Targeting Advanced Multiple Myeloma Cases.

Buprenorphine Hydrochloride, approved in the US in 1981, is made by Indivior and used for pain management when other treatments are inadequate.

ATA3219, an off-the-shelf CAR T treatment by Atara Biotherapeutics, gets green light from the FDA for its IND submission targeting Lupus Nephritis.

Aspirin, also known as acetylsalicylic acid (ASA), is a widely used nonsteroidal anti-inflammatory drug (NSAID) that helps reduce pain, fever, and inflammation while also acting as an antithrombotic.

UK regulators have approved Ariceum Therapeutics to initiate an early-stage trial with its innovative I-123 tagged PARP blocker for individuals experiencing repeated glioblastoma.

Sucralfate is a medication that was first approved in Japan in February 1968 by Allergan.

Jacobio Pharmaceuticals Secures U.S. Go-Ahead for Experimental P53 Y220C Stimulant JAB-30300 under Investigational New Drug Status.

Risperidone, marketed under the trade name RISPERDAL®, is an atypical antipsychotic medication that was first approved by the US Food and Drug Administration (FDA) on December 29, 1993.

Innovent Reveals Initial Subject Receives Dose in Australian Phase 1 Trial for IBI3002 (a dual-action antibody targeting IL-4Rα and TSLP).

Diltiazem,sold under the brand name Cardizem among others, is a calcium ion cellular influx inhibitor (slow channel blocker or calcium antagonist).

Biocon Biologics, a fully owned arm of Biocon Ltd and a global player in biosimilars, announced today a settlement and license agreement with Janssen Biotech Inc. and Johnson & Johnson.